Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biocept Inc (BIOC)

Biocept Inc (BIOC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biocept Inc 9955 Mesa Rim Road San Diego CA 92121 USA

P: 858-320-8200 F: 858-320-8225

Description:

Biocept, Inc. is a commercial stage oncology diagnostics company. It has developed technology platforms for capture and analysis of circulating tumor cells and circulating tumor DNA utilizing a standard blood sample to provide physicians. The company offers OncoCEE-BR (TM) test for breast cancer. Biocept, Inc. is headquartered in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 16,148
Shares Outstanding, K 16,923
Annual Sales, $ 61,250 K
Annual Net Income, $ -2,820 K
Last Quarter Sales, $ 19,950 K
Last Quarter Net Income, $ -2,770 K
60-Month Beta 0.82
% of Insider Shareholders 1.39%
% of Institutional Shareholders 13.52%
Float, K 16,688
% Float 98.61%
Short Volume Ratio 0.31

Growth:

1-Year Return -76.27%
3-Year Return -90.74%
5-Year Return -99.79%
5-Year Revenue Growth 1,802.17%
5-Year Earnings Growth 99.97%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.16 on 05/23/22
Next Earnings Date 08/15/22
Earnings Per Share ttm -0.45
EPS Growth vs. Prev Qtr 11.11%
EPS Growth vs. Prev Year -184.21%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 09/08/20

BIOC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -19.99%
Return-on-Assets % -12.16%
Profit Margin % -4.60
Net Margin % 3.63
Debt/Equity 0.03
Price/Sales 0.26
Price/Cash Flow N/A
Price/Book 0.43
Book Value/Share 2.19
Interest Coverage -8.31
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar